Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analyses.
Peeva E, Yamaguchi Y, Ye Z, King B, Picardo M, Sloan A, Ezzedine K, Del Duca E, Estrada Y, Hassan-Zahraee M, He W, Hyde C, Bar J, Facheris P, Guttman-Yassky E.
Peeva E, et al. Among authors: king b.
Exp Dermatol. 2024 Sep;33(9):e15177. doi: 10.1111/exd.15177.
Exp Dermatol. 2024.
PMID: 39304339
Clinical Trial.